Your browser doesn't support javascript.
loading
Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution.
Recio-Boiles, Alejandro; Vondrak, Jessica; Veeravelli, Summana; Mancuso, James J; Saboda, Kathylynn; Roe, Denise J; Riaz, Irbaz Bin; Scott, Aaron J; Elquza, Emad; McBride, Ali; Babiker, Hani M.
Afiliação
  • Recio-Boiles A; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA.
  • Vondrak J; Department of Internal Medicine, University of Arizona, Tucson, AZ, USA.
  • Veeravelli S; Department of Internal Medicine, University of Arizona, Tucson, AZ, USA.
  • Mancuso JJ; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Saboda K; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA.
  • Roe DJ; University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.
  • Riaz IB; Mayo Clinic, Rochester, MN, USA.
  • Scott AJ; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA.
  • Elquza E; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA.
  • McBride A; University of Arizona College of Pharmacy, Tucson, AZ, USA.
  • Babiker HM; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA.
Article em En | MEDLINE | ID: mdl-32313882

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article